128 related articles for article (PubMed ID: 24345573)
1. Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats.
Geed M; Garabadu D; Ahmad A; Krishnamurthy S
Pharmacol Biochem Behav; 2014 Feb; 117():92-103. PubMed ID: 24345573
[TBL] [Abstract][Full Text] [Related]
2. Silibinin attenuates MPP⁺-induced neurotoxicity in the substantia nigra in vivo.
Jung UJ; Jeon MT; Choi MS; Kim SR
J Med Food; 2014 May; 17(5):599-605. PubMed ID: 24660866
[TBL] [Abstract][Full Text] [Related]
3. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
Lee Y; Park HR; Chun HJ; Lee J
J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
[TBL] [Abstract][Full Text] [Related]
4. S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice.
Rojas P; Serrano-García N; Medina-Campos ON; Pedraza-Chaverri J; Maldonado PD; Ruiz-Sánchez E
J Nutr Biochem; 2011 Oct; 22(10):937-44. PubMed ID: 21190833
[TBL] [Abstract][Full Text] [Related]
5. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
Zhai A; Zhu X; Wang X; Chen R; Wang H
Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
[TBL] [Abstract][Full Text] [Related]
6. Rosmarinic acid antagonized 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in MES23.5 dopaminergic cells.
Du T; Li L; Song N; Xie J; Jiang H
Int J Toxicol; 2010 Dec; 29(6):625-33. PubMed ID: 20966113
[TBL] [Abstract][Full Text] [Related]
7. Induction of ferroxidase enzymatic activity by copper reduces MPP+-evoked neurotoxicity in rats.
Rubio-Osornio M; Montes S; Heras-Romero Y; Guevara J; Rubio C; Aguilera P; Rivera-Mancia S; Floriano-Sánchez E; Monroy-Noyola A; Ríos C
Neurosci Res; 2013 Mar; 75(3):250-5. PubMed ID: 23298529
[TBL] [Abstract][Full Text] [Related]
8. Purinergic Antagonism Prevents Mitochondrial Dysfunction and Behavioral Deficits Associated with Dopaminergic Toxicity Induced by 6-OHDA in Rats.
Kumar S; Mishra A; Krishnamurthy S
Neurochem Res; 2017 Dec; 42(12):3414-3430. PubMed ID: 28836128
[TBL] [Abstract][Full Text] [Related]
9. 1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum.
Nakai M; Mori A; Watanabe A; Mitsumoto Y
Exp Neurol; 2003 Jan; 179(1):103-10. PubMed ID: 12504872
[TBL] [Abstract][Full Text] [Related]
10. Copper sulfate pretreatment prevents mitochondrial electron transport chain damage and apoptosis against MPP
Rubio-Osornio M; Orozco-Ibarra M; Díaz-Ruiz A; Brambila E; Boll MC; Monroy-Noyola A; Guevara J; Montes S; Ríos C
Chem Biol Interact; 2017 Jun; 271():1-8. PubMed ID: 28442376
[TBL] [Abstract][Full Text] [Related]
11. Zocor Forte (simvastatin) has a neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP+ does not.
Santiago M; Hernández-Romero MC; Machado A; Cano J
Eur J Pharmacol; 2009 May; 609(1-3):58-64. PubMed ID: 19292984
[TBL] [Abstract][Full Text] [Related]
12. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
[TBL] [Abstract][Full Text] [Related]
13. The neuroprotective effect of lovastatin on MPP(+)-induced neurotoxicity is not mediated by PON2.
Aguirre-Vidal Y; Montes S; Tristan-López L; Anaya-Ramos L; Teiber J; Ríos C; Baron-Flores V; Monroy-Noyola A
Neurotoxicology; 2015 May; 48():166-70. PubMed ID: 25842176
[TBL] [Abstract][Full Text] [Related]
14. [Protective effects of puerarin against 1-methyl-4-phenylpyridinium-induced mitochondrial apoptotic death in differentiated SH-SY5Y cells].
Cheng Y; Zhu G; Guan Y; Liu Y; Hu Y; Li Q
Zhongguo Zhong Yao Za Zhi; 2011 May; 36(9):1222-6. PubMed ID: 21842654
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats.
Sairam K; Saravanan KS; Banerjee R; Mohanakumar KP
Brain Res; 2003 Mar; 966(2):245-52. PubMed ID: 12618347
[TBL] [Abstract][Full Text] [Related]
16. Baicalein attenuates α-synuclein aggregation, inflammasome activation and autophagy in the MPP
Hung KC; Huang HJ; Wang YT; Lin AM
J Ethnopharmacol; 2016 Dec; 194():522-529. PubMed ID: 27742410
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons.
Alvira D; Tajes M; Verdaguer E; de Arriba SG; Allgaier C; Matute C; Trullas R; Jiménez A; Pallàs M; Camins A
Neuroscience; 2007 Apr; 146(1):350-65. PubMed ID: 17343987
[TBL] [Abstract][Full Text] [Related]
18. Striatal ablation of GABAergic neurons prevents the in vivo neuroprotective effect of DCG-IV against the MPP+-induced neurotoxicity on dopaminergic nerve terminals.
Venero JL; Mauriño R; Machado A; Santiago M
Neurochem Int; 2010 Dec; 57(8):979-84. PubMed ID: 20974202
[TBL] [Abstract][Full Text] [Related]
19. Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway.
Chen ST; Chuang JI; Hong MH; Li EI
J Pineal Res; 2002 May; 32(4):262-9. PubMed ID: 11982797
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells.
Zhang S; Wang J; Song N; Xie J; Jiang H
Neurobiol Aging; 2009 Sep; 30(9):1466-76. PubMed ID: 18191877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
